(Q42676208)

4 November 2017

title

An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis (English)

1 reference

4 November 2017

0 references

1 reference

Arca E

1

1 reference

4 November 2017

Taştan HB

2

1 reference

4 November 2017

Akar A

3

1 reference

4 November 2017

Kurumlu Z

4

1 reference

4 November 2017

Gür AR

5

1 reference

4 November 2017

publication date

1 March 2002

1 reference

Journal of Dermatological Treatment

4 November 2017

published in

1 reference

4 November 2017

volume

13

1 reference

4 November 2017

issue

1

1 reference

4 November 2017

page(s)

3-9

1 reference

Short term treatment of dermatophyte onychomycosis with terbinafine

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09546630252775171

Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630252775171

Onychomycosis: successful treatment with once-weekly fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630252775171

Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630252775171

Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630252775171

Itraconazole-induced acute hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630252775171

Hepatic injury associated with itraconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630252775171

Risk/benefit ratio of modern antifungal therapy: focus on hepatic reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630252775171

The treatment of dermatophytosis: safety considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630252775171

10.1080/09546630252775171

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference